Angiographic Catheters Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Angiographic Catheters Market is segmented By Product Type (Scoring balloon catheters, Conventional Catheters, Cutting balloon catheters, Drug-Eluting Balloon Catheters), By Application (Endovascular, Coronary (Neurology, Oncology), Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Angiographic Catheters Market Size

The Global Angiographic Catheters Market reached USD 1,257.3 million in 2022 and is projected to witness lucrative growth by reaching up to USD 2,229.8 million by 2031. The global angiographic catheters market is expected to exhibit a CAGR of 7.6% during the forecast period (2024-2031). Angiographic catheters are used to determine the health of your blood vessels and how blood flows through them.

It can aid in the diagnosis or investigation of a variety of blood vessel issues, including atherosclerosis which is a narrowing of the arteries that increases your chance of having a stroke or heart attack.

The rise in demand for minimally invasive procedures and an increase in the geriatric population are expected to drive the growth of the market. The development of new multi-specialty hospitals is expected to generate higher demand for various angiographic catheters over the forecast period.

Angiographic Catheters Market Scope

For more Insights Request Free Sample

Angiographic Catheters Market Dynamics

The Growing Regularity of Cardiovascular Disorders and the Increasing Number of Heart Surgeries 

Rapid technical advancements in medical equipment, as well as rising government expenditures for the construction of healthcare infrastructure, are important factors driving the market. Because of expanding disposable income, higher purchasing capacity, and advantageous reimbursement policies, consumers are more convinced to employ innovative healthcare devices.

For instance, the data published by the European Heart Network in 2021 reported that in the European Union, more than 60 million people live with cardiovascular disease, and close to 13 million new cases of cardiovascular diseases are diagnosed every year. 

Such increasing prevalence of cardiovascular diseases which led to an increasing need for early diagnosis and treatment is expected to drive the growth of the angiographic catheters market.

High Cost of Surgeries

The biggest element impeding market expansion is government restrictions on controlling product approval. The availability of alternative therapy, as well as issues with angiographic catheters, are further impeding market expansion.

Also, one of the reasons is the high cost involved in research and development in order to assure the safety and efficacy of medical devices, including angiographic catheters, extensive research, testing, and clinical studies are conducted. These expenses are very costly and frequently included in the final product's price.

Angiographic Catheters Market Segment Analysis

The global angiographic catheters market is segmented based on product type, application and end user .

Hospital Segment is Expected to Hold Significant Market Share in the Market During The Forecast Period. 

The hospital segment is estimated to account for 42.3% of total market revenue. The hospital segment is expected to dominate the overall angiographic catheter market. The factors attributing to the dominance of this segment are enhanced healthcare infrastructure, availability of skilled labor, and affordability. 

The rise in the patient pool, owing to substantial growth in the geriatric population suffering from lifestyle diseases, such as atherosclerosis and heart failure, is expected to enhance revenue generations of the hospitals.

Source: DataM Intelligence Analysis (2023)

Angiographic Catheters Market Geographical Share

North America is the Dominating Region Accounting for 41.7% During the Forecast Period

North America has a huge market because of the increased acceptance of sophisticated technologies and the presence of large market participants in this area, North America dominates the angiographic catheter market. Furthermore, increased occurrences of cardiovascular disease and an aging population will boost the market's growth pace. In North America, angiographic catheters are routinely utilized for diagnostic and interventional treatments in cardiology and radiology. 

These catheters are intended to access and travel blood arteries in order to visualize and treat a variety of illnesses. In North America, there are various angiographic catheter manufacturers and suppliers. They have a wide selection of catheters with various shapes, sizes, and configurations to suit different clinical needs.

Source: DataM Intelligence Analysis (2023)

Angiographic Catheters Companies

The major global players include Medtronic, Boston Scientific Corporation, Terumo Medical Corporation, Cardinal Health, Merit Medical Systems, Inc, Abbott, Aachen Resonance Entwicklungsgesellschaft Mbh, Zoll Medical Corporation, Contego Medical, Inc, Asahi Intec Co. Ltd, and Cardio novum Gmbh.

Key Developments

• In February 2023, Abbott receives fresh FDA approval for one catheter and CE mark approval for a second catheter. Abbott announced two significant regulatory approvals, one in the United States and one in Europe. First, the company's Flex Ability Sensor Enabled Ablation Catheter was approved for a new indication by the US Food and Drug Administration (FDA). The device is currently authorized as a therapy option for non-ischemic cardiomyopathy patients with ventricular tachycardia (VT).
• In May 2023, Shockwave Medical (SWAV) introduced a new IVL catheter in the United States SWAV announced that the Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) Catheter is now fully commercially available in the United States. This comes after receiving FDA approval for the same. The Shockwave L6 catheter will most likely add to the company's peripheral IVL portfolio, expanding the size options of the Shockwave M5+ and Shockwave S4 catheters. 
• In May 2022, Medtronic announced that the IN. PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, a drug coated balloon (DCB), has received FDA approval for the interventional treatment of peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries. PAD, a build-up of plaque in the walls of arteries that slows or stops the flow of oxygen-rich blood to the limbs, affects 12 million people in the United States alone,1 and half of these patients go untreated, increasing the risk of amputation.

Why Purchase the Report?

• To visualize the global angiographic catheters market segmentation based on the product, application, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of global angiographic catheters market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global angiographic catheters market report would provide approximately 92 tables, 108 figures and 195 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies